Johnson & Johnson ‘under stress’ to meet EU vaccine supply goal

Any delay would be a further blow to EU's vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow rollout of shots in many member states

Tue, 09 Mar, 2021 - 17:00

Francesco Guarascio (Reuters)

Johnson & Johnson (J&J) has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its Covid-19 vaccine to the bloc in the second quarter of the year.

Any delay would be a further blow to EU's vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow rollout of shots in many member states.